Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitively-enhanced tDCS of the Dorsolateral Prefrontal Cortex to Reduce Craving in Cocaine Addiction

NCT07318480 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT07318480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07318480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitively-enhanced tDCS of the Dorsolateral Prefrontal Cortex to Reduce Craving in Cocaine Addiction
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Not applicable
Overall status
Recruiting
Start date
February 25, 2026
Completion date
February 28, 2030
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine dependence, cocaine use disorder, opioid dependence, opioid use disorder, substance use disorder (sud)